Providing High Quality Care through Sustainable and Innovative Systems

The mandate of the IDI Prevention, Care and Treatment (PCT) Programme is to provide high quality multidisciplinary care through sustainable and innovative systems, which can be used for research and capacity building.

Towards Patient-Centered Care 

This year, the PCT Adult Infectious Diseases Clinic (AIDC) located at the IDI site in Mulago has implemented differentiated care models that provide specialised clinical services for patients with complex conditions, while at the same time increasing intervals between visits for stable patients. The AIDC is accredited by the Ministry of Health Uganda (MoH), and by June 2016 was providing general and specialized HIV care to approximately 7,800 patients. The specialised clinics provide HIV care for mental health, TB, sexual reproductive health, adolescents, non-communicable diseases and elderly patients, among others. 

Patient Safety

The AIDC has implemented patient safety initiatives that include incident reporting and pharmacovigilance. Currently, there is a medication safety project that is being conducted in collaboration with the University of Liverpool, to better understand harm arising from medical prescription errors among patients receiving ART; with the higher goal of developing appropriate interventions for Uganda and similar resource-limited settings. This study is being conducted at IDI, and in rural and urban hospitals, and it will provide a first view of the burden arising from antiretroviral medication errors.  

To strengthen patient participation in safety issues, the clinic is piloting a training programme for young adults to promote patient safety in HIV clinics. Specifically, the young adults will be trained to support other IDI patients to take greater ownership of their care, to bring voices of patients to the forefront of health care at IDI, and to create partnerships between patients, family members and other health care stakeholders.

Developing Capacity for Clinical Research in Emerging Infectious Diseases

With support from the World Health Organization Tropical Diseases Research (WHO-TDR) and the European and Developing Countries Clinical Trials Partnership (EDCTP), the PCT Programme is developing its capacity to act as a platform for clinical research for phase 1 clinical trials with a focus on investigational drugs for viral hemorrhagic fevers. This project promotes infection prevention and control among staff, and supports the provision of clinical and laboratory equipment for high quality clinical research.

The Ugandan Academy for Health Innovation and Impact

On 17th November 2015, The Ugandan Academy for Health Innovation and Impact was officially inaugurated at the IDI McKinnell Knowledge Centre at Makerere University. During the inauguration, an MOU was signed between IDI, MoH, the Johnson & Johnson Corporate Citizenship Trust and Janssen, and the Pharmaceutical Companies of Johnson & Johnson, as the basis of the new partnership. The Ugandan Academy will fund multiple projects over the next five years initially focusing on HIV and TB clinical management, capacity building and applied research to address urgent health needs in Uganda. The Ugandan Academy is the flagship implementation of Connect for Life™ – a Janssen program that empowers healthcare work¬ers, academics and patients to address critical health challenges, including HIV, TB, and maternal and child health in innovative, collaborative, and context-appropriate ways. 

The Ugandan Academy is currently running three demonstration projects in the areas of clinical management, capacity building and research.  The clinical management project is an e-health project that aims to promote healthy behaviors and adherence to treatment by providing people living with HIV with treatment adherence and visit reminders, health tips, as well as symptom management support through voice call and text messages. The capacity-building demonstration project is aimed at providing educational opportunities for healthcare workers and increasing access to educational resources and subject matter experts through electronic media. Under this project, an e-learning website was launched in June 2016, providing interactive open-access resources to healthcare workers locally and globally. The e-learning website can be accessed at: As another capacity building model, The Ugandan Academy is also providing sponsorship to Masters and PhD students. The research demonstration project is the Drug Resistance in Long Term HIV Demonstration Project. This is a prospective observational study underway at IDI Mulago with the objective of investigating the virological outcomes in 1,000 HIV infected patients who have been on ART for ten years, which builds on a cohort study of 500 patients who started ART in 2004/5. So far, the study has demonstrated 95% viral suppression amongst participants.

Global Health Security Agenda (GHSA) Project

In October 2015, IDI was awarded a five-year grant from the US Centers for Disease Control and Prevention (CDC) to work with the MoH to build public sector capacity in four target areas of the GHSA: biosafety and biosecurity, laboratory systems strengthening, prevention of antimicrobial resistance, and acute febrile illness surveillance. The GHSA Project has supported the MoH to revise the biosafety and biosecurity curriculum, and has trained over 60 trainers using the harmonized curriculum. The project also worked towards setting up a National Biosafety and Biosecurity Association, which currently has 33 members. 

Under laboratory systems strengthening, IDI is working with the Uganda National Health Laboratory Services (UNHLS) and the Department of Medical Microbiology at Makerere University College of Health Sciences to develop a National Microbiology Network. Laboratory quality management systems for microbiology are being developed at UNHLS (now at 40% capacity) and three regional hospital laboratories (Jinja, Mubende and Arua). The three regional hospital laboratories have been provided with microbiology supplies and basic equipment, while the UNHLS has been supported to relocate to its new complex in Butabika. Through this built capacity, case-based surveillance for bacterial and viral infections in children has commenced at the three sites.

To read the full IDI 2015/2016, follow the Resources page in the menu bar, and click the Annual Reports link.